SCHEMBL18398306

SCHEMBL18398306

CCc1cc(C#N)c(F)cc1Nc1cc2c(ncn2C)c(NC(=O)c2ccc(OC)cc2OC)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 1/20 0.39
▸ NPC1 O15118 6/20 0.37
▸ RAB9A P51151 6/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ TP53 P04637 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ TSHR P16473 1/20 0.37
▸ FGFR4 P22455 2/20 0.37
▸ MITF O75030 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ GPR6 P46095 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAPK8 P45983 1/20 0.35
▸ MAPK9 P45984 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398263 0.87 NPC1 (0.40) CFTRNPC1RAB9AALDH1A1KMT2A
SCHEMBL18398308 0.86 MAPT (0.40) NPC1RAB9AALDH1A1KMT2ATP53
SCHEMBL18398419 0.86 CFTR (0.38) CFTRNPC1RAB9AALDH1A1KMT2A
SCHEMBL18398361 0.85 JAK2 (0.40) CFTRNPC1RAB9AALDH1A1KMT2A
SCHEMBL18398424 0.81 GPR6 (0.39) CFTRNPC1RAB9AALDH1A1KMT2A
SCHEMBL18398203 0.80 GPR6 (0.37) CFTRNPC1RAB9AALDH1A1KMT2A
SCHEMBL18398299 0.80 PDE4A (0.38) CFTRNPC1RAB9AALDH1A1KMT2A
SCHEMBL18409202 0.80 TYK2 (0.53) ALDH1A1TSHRMAPK1LMNAHSD17B10
SCHEMBL18398542 0.80 GPR6 (0.40) CFTRNPC1RAB9AALDH1A1KMT2A
SCHEMBL18398471 0.78 JAK2 (0.52) CFTRNPC1RAB9AALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback